Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #46 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 11 Dec 2018 | Procter & Gamble Overseas India B. V. | Promoter | Buy | 0 | ₹0 |
| 4 Dec 2018 | MERCK INTERNATIONALE BETEILIGUNGEN GMBH | Promoter group | Sell | 0 | ₹0 |
| 4 Dec 2018 | CHEMITRA GESELLSCHAFT MIT BESCHRANKTER HAFTUNG | Promoter group | Sell | 0 | ₹0 |
| 4 Dec 2018 | Emedia Export Company Mit Beschrankter Haftung | Promoter group | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 3 Oct 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | Block | Buy | 6,405 | 4106.9500 | NSE |
| 3 Oct 2022 | ISHARES INDIA SC MAURITIUS COMPANY | Block | Sell | 6,405 | 4106.9500 | NSE |
| 3 Oct 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | Block | Buy | 44,711 | 4106.9500 | NSE |
| 3 Oct 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 44,711 | 4106.9500 | NSE |
| 19 Sep 2022 | ISHARES INDIA SC MAURITIUS COMPANY | Block | Sell | 3,433 | 4147.5000 | BSE |
| 19 Sep 2022 | ISHARES MSCI INDIA SMALL-CAP ETF | Block | Buy | 3,433 | 4147.5000 | BSE |
| 19 Sep 2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | Block | Buy | 23,964 | 4147.5000 | BSE |
| 19 Sep 2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 23,964 | 4147.5000 | BSE |
| 6 Oct 2010 | HDFC MUTUAL FUND AC HDFC MONTHLY INCOME PLAN LONG TERM | Bulk | Sell | 248,994 | 730.0000 | BSE |
| 6 Oct 2010 | SBI MUTUAL FUND AC MAGNUM SECTOR FUND UMBRELLA CONTRA | Bulk | Buy | 249,000 | 729.9800 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| — | Final Dividend - Rs. - 45.0000 | — | — |
| 27 Aug 2026 | Dividend - Rs 45 Per Share | 45.0000 | 27 Aug 2026 |
| 12 Feb 2026 | Interim Dividend - Rs 110 Per Share & Special Dividend Rs 50 Per Share | 110.0000 | 12 Feb 2026 |
| 22 Aug 2025 | Dividend - Rs 45 Per Share | 45.0000 | 22 Aug 2025 |
| 21 Feb 2025 | Interim Dividend - Rs 80 Per Share | 80.0000 | 21 Feb 2025 |
| 28 Nov 2024 | Annual General Meeting/Dividend - Rs 60 Per Share | 60.0000 | — |
| 14 Feb 2024 | Interim Dividend - Rs 50 Per Share & Special Dividend Rs 150 Per Share | 50.0000 | 14 Feb 2024 |
| 23 Nov 2023 | Annual General Meeting/Dividend - Rs 50 Per Share | 50.0000 | — |
| 13 Feb 2023 | Interim Dividend - Rs 45 Per Share | 45.0000 | 13 Feb 2023 |
| 15 Nov 2022 | Annual General Meeting/Dividend - Rs 11.50 Per Share | 11.5000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from E. Merck (India) Ltd to Merck Ltd. |
| — | NAME_CHANGE | Name changed from Merck Ltd. to PROCTER & GAMBLE HEALTH LIMITED |
| 27 Mar 2012 | OTHER | Annual General Meeting |
| 21 Mar 2011 | OTHER | Annual General Meeting |
| 6 Apr 2009 | AGM | Agm/Div-Rs.17.50 Per Shre |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 6 Aug 2026 | Financial Results | Yes |
| 26 May 2026 | Financial Results/Dividend | Yes |
| 6 Feb 2026 | Financial Results | Yes |
| 6 Feb 2026 | Financial Results/Dividend | Yes |
| 5 Nov 2025 | Financial Results/Dividend | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
